Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SULIMAN, M. E.
Right arrow Articles by BERGSTROM, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SULIMAN, M. E.
Right arrow Articles by BERGSTROM, J.
J Am Soc Nephrol 10:1287-1296, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Effects of High-Dose Folic Acid and Pyridoxine on Plasma and Erythrocyte Sulfur Amino Acids in Hemodialysis Patients

MOHAMED E. SULIMAN*, JOSÉ C. DIVINO FILHO{dagger}, PETER BÀRÀNY*, BJÖRN ANDERSTAM*, BENGT LINDHOLM* and JONAS BERGSTROM*

* Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Huddinge University Hospital, Karolinska Institute, Sweden.
{dagger} Sophiahemmet Dialysis Unit, Stockholm, Sweden.

Correspondence to Dr. Jonas Bergström, Divisions of Baxter Novum and Renal Medicine, K-56, Huddinge University Hospital, Karolinska Institute, S-141 86 Huddinge, Sweden. Phone: 46 87 462607; Fax: 46 87 114742; E-mail: jonaberg{at}kfcd05.hs.sll.se

Abstract. In this investigation, sulfur amino acids (sAA) and sulfhydryls were determined in the plasma and erythrocytes (RBC) of 10 uremic patients on regular hemodialysis (HD) treatment and 10 healthy subjects, before and after supplementation with 15 mg/d of folic acid and 200 mg/d of pyridoxine for 4 wk. The basal total plasma concentrations of homocysteine (Hcy), cysteine (Cys), cysteinylglycine (Cys-Gly), {gamma}-glutamylcysteine ({gamma}-Glu-Cys), glutathione (GSH), and free cysteinesulfinic acid (CSA) were significantly higher in HD patients when compared to healthy subjects, whereas methionine (Met) and taurine (Tau) concentrations were the same in the two groups. HD patients showed significantly higher RBC levels of Hcy and Cys-Gly, whereas the RBC concentrations of Met, Cys, Tau, and GSH were not different from those in the healthy subjects. The plasma concentrations of sAA and sulfhydryls differed compared with RBC levels in the healthy subjects and HD patients. In both groups, supplementation with high doses of folic acid and pyridoxine reduced the plasma Hcy concentration. In addition, increased plasma concentrations of Cys-Gly and GSH were found in the HD patients and of CSA in the healthy subjects. After vitamin supplementation, the RBC concentrations of Hcy, Cys, and GSH increased and that of Tau decreased in healthy subjects. The only significant finding in RBC of HD patients was an increase in GSH levels after supplementation. This study shows several RBC and plasma sAA and sulfhydryl abnormalities in HD patients, which confirms earlier findings that RBC and plasma pools play independent roles in interorgan amino acid transport and metabolism. Moreover, high-dose supplementation with folic acid and pyridoxine significantly reduced Hcy levels, but did not restore the sAA and sulfhydryl abnormalities to normal levels. The increase that was observed in GSH after vitamin supplementation may have a beneficial effect in improving blood antioxidant status in uremic patients. Finally, the findings of elevated plasma Cys levels correlating to the elevated plasma Hcy levels in the presence of elevated plasma CSA levels, both before and after vitamin supplementation, led to the hypothesis that a block in decarboxylation of CSA is linked to hyperhomocysteinemia in end-stage renal failure.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
I. M. Frey, I. Rubio-Aliaga, A. Siewert, D. Sailer, A. Drobyshev, J. Beckers, M. H. de Angelis, J. Aubert, A. B. Hen, O. Fiehn, et al.
Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice
Physiol Genomics, February 12, 2007; 28(3): 301 - 310.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. van Guldener
Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1161 - 1166.
[Full Text] [PDF]


Home page
J. Nutr.Home page
S. R. Davis, E. P. Quinlivan, P. W. Stacpoole, and J. F. Gregory III
Plasma Glutathione and Cystathionine Concentrations Are Elevated but Cysteine Flux Is Unchanged by Dietary Vitamin B-6 Restriction in Young Men and Women
J. Nutr., February 1, 2006; 136(2): 373 - 378.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Santangelo, V. Witko-Sarsat, T. Drueke, and B. Descamps-Latscha
Restoring glutathione as a therapeutic strategy in chronic kidney disease
Nephrol. Dial. Transplant., August 1, 2004; 19(8): 1951 - 1955.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Garibotto, A. Sofia, S. Saffioti, R. Russo, G. Deferrari, D. Rossi, D. Verzola, M. T. Gandolfo, and M. R. Sala
Interorgan exchange of aminothiols in humans
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E757 - E763.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. E. Suliman, P. Barany, J. C. D. Filho, A. R. Qureshi, P. Stenvinkel, O. Heimburger, B. Anderstam, B. Lindholm, and J. Bergstrom
Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1050 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. E. Suliman, J. C. D. Filho, P. Barany, B. Anderstam, B. Lindholm, and J. Bergstrom
Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients
Nephrol. Dial. Transplant., January 1, 2001; 16(1): 102 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. SUNDER-PLASSMANN, M. FÖDINGER, H. BUCHMAYER, M. PAPAGIANNOPOULOS, J. WOJCIK, J. KLETZMAYR, B. ENZENBERGER, O. JANATA, W. C. WINKELMAYER, G. PAUL, et al.
Effect of High Dose Folic Acid Therapy on Hyperhomocysteinemia in Hemodialysis Patients: Results of the Vienna Multicenter Study
J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1106 - 1116.
[Abstract] [Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP